IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting
Provided By GlobeNewswire
Last update: Nov 5, 2024
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced an upcoming poster presentation at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, being hosted December 7 – 10, 2024 in San Diego, CA.
Read more at globenewswire.comNASDAQ:INAB (12/12/2025, 11:29:47 AM)
1.81
+0.08 (+4.62%)
Find more stocks in the Stock Screener
